Skip to content
healthcare.dev

Tizanidine

NDC 70518-3112, Tizanidine, tablet, from REMEDYREPACK INC..

Product NDC
70518-3112
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076286
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-3112 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIZANIDINE HYDROCHLORIDE2 mg/1

Pharmacologic classes

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
70518-3112-07051831120060 TABLET in 1 BOTTLE, PLASTIC (70518-3112-0)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7bbc81e5-ad3e-496b-908f-e6f500f6ad7e

Use it

Look up 70518-3112 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-3112 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-3112. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.